|
Volumn 13, Issue 2, 2007, Pages
|
Why do so many clinicians believe that recurrent zoster is common?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PREDNISOLONE;
VALACICLOVIR;
VARICELLA ZOSTER VACCINE;
ACTINIC RETICULOID;
CLINICAL PRACTICE;
EPIDEMIC;
HERPES ZOSTER;
HUMAN;
IMMUNE DEFICIENCY;
INFECTION PREVENTION;
INFECTION RISK;
NONHUMAN;
NOTE;
RECURRENT DISEASE;
VARICELLA ZOSTER VIRUS;
VESICULAR RASH;
VIRUS CULTURE;
VIRUS TRANSMISSION;
AGED;
ARTICLE;
FEMALE;
HOSPITALIZATION;
IMMUNOCOMPETENCE;
IMMUNOLOGY;
INCIDENCE;
MALE;
MIDDLE AGED;
PROGNOSIS;
RISK ASSESSMENT;
AGED;
FEMALE;
HERPES ZOSTER;
HUMANS;
IMMUNOCOMPETENCE;
INCIDENCE;
MALE;
MIDDLE AGED;
PROGNOSIS;
RECURRENCE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
|
EID: 34248168725
PISSN: None
EISSN: 10872108
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (9)
|
References (6)
|